OrganoClick AB (ORGC) AI Stock Analysis

• Market Cap: kr189.76M
• Dividend Yield: N/A
• Average Volume (3M): 81.04K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.16
• Revenue Growth: -16.35%
• EPS Growth: -33.91%
• Country: SE
• Employees: 40
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): -0.06
• Shares Outstanding: 110,003,010
• 10 Day Avg. Volume: 100,374
• 30 Day Avg. Volume: 81,039
• PEG Ratio: -1.25
• Price to Book (P/B): 9.71
• Price to Sales (P/S): 2.21
• P/FCF Ratio: -51.08
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: kr1.54
• Price Target Upside: -11.06% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 41 Neutral
• Price Target: kr1.50 ▼(-13.29% Downside)

OrganoClick AB's overall stock score is primarily driven by its poor financial performance, characterized by declining revenues, high leverage, and weak cash flow. Technical analysis further indicates bearish trends, with the stock trading below key moving averages. The negative P/E ratio and lack of dividend yield also contribute to a weak valuation score.

OrganoClick AB Business Overview & Revenue Model

Company Description

OrganoClick AB is a Swedish company specializing in the development and production of environmentally friendly chemical products and technologies. The company's core focus is on creating sustainable alternatives for traditional chemical solutions in sectors such as textiles, construction, and paper. OrganoClick's innovative technologies include biobased binders, water-repellent and flame-retardant coatings, and biodegradable polymers, all aiming to reduce environmental impact while maintaining high performance standards.

How the Company Makes Money

OrganoClick AB generates revenue through the sale of its proprietary environmentally friendly products and licensing of its technologies. The company's key revenue streams include the sale of biobased binders for nonwoven materials, water-repellent and flame-retardant treatments for textiles, and biodegradable binders for paper and packaging industries. Additionally, OrganoClick collaborates with various industry partners to integrate its sustainable solutions into their products, further expanding its market reach and revenue potential. Strategic partnerships and continuous innovation in green chemistry are significant factors contributing to the company's earnings growth.

OrganoClick AB Financial Statement Overview

Summary

OrganoClick AB faces significant financial challenges, with declining revenue, persistent losses, high leverage, and negative cash flow growth. The company's profitability is weak, as evidenced by negative net profit and cash flow margins, though the gross profit margin is somewhat decent.

Income Statement

OrganoClick AB's income statement shows declining revenue and persistent losses. The TTM (Trailing-Twelve-Months) reveals a gross profit margin of approximately 23.8%, but the net profit margin is negative, indicating struggles with profitability. Revenue growth is inconsistent, and EBIT and EBITDA margins are negative, highlighting operational inefficiencies.

Balance Sheet

The balance sheet indicates a high debt-to-equity ratio, suggesting significant leverage. The equity ratio stands at about 14.6% TTM, reflecting low equity relative to assets. Persistent net losses have impacted return on equity negatively. The company's financial stability is a concern due to high liabilities and diminishing equity.

Cash Flow

Cash flow analysis reveals negative free cash flow TTM, highlighting cash generation challenges. The operating cash flow to net income ratio is negative, indicating core operational cash flow issues. The growth of free cash flow is negative, pointing to cash management difficulties.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	115.67M	127.23M	145.87M	115.05M	110.06M	96.46M
Gross Profit	24.77M	31.84M	35.39M	12.94M	18.51M	20.20M
EBITDA	-893.00K	5.71M	5.95M	-21.19M	-12.92M	-4.41M
Net Income	-22.89M	-17.97M	-15.77M	-41.62M	-31.03M	-19.52M
Balance Sheet
Total Assets	163.08M	126.98M	150.75M	162.86M	188.39M	152.80M
Cash, Cash Equivalents and Short-Term Investments	2.34M	538.00K	10.74M	15.20M	34.25M	32.03M
Total Debt	78.03M	50.56M	62.39M	60.68M	53.54M	43.36M
Total Liabilities	134.85M	89.15M	97.34M	95.30M	80.66M	69.86M
Stockholders Equity	20.42M	28.98M	44.58M	58.78M	100.33M	54.08M
Cash Flow
Free Cash Flow	-10.78M	-5.51M	-8.08M	-35.35M	-52.34M	-13.93M
Operating Cash Flow	266.00K	3.60M	533.00K	-21.22M	-37.69M	5.47M
Investing Cash Flow	-11.05M	-9.11M	-8.61M	-7.45M	-14.65M	-19.40M
Financing Cash Flow	-2.58M	-4.69M	3.60M	9.63M	54.56M	-15.19M

OrganoClick AB Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1.73
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:ORGC, the sentiment is Negative. The current price of 1.73 is below the 20-day moving average (MA) of 1.78, below the 50-day MA of 1.81, and below the 200-day MA of 2.24, indicating a bearish trend. The MACD of -0.03 indicates Positive momentum. The RSI at 44.72 is Neutral, neither overbought nor oversold. The STOCH value of 49.37 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:ORGC.

OrganoClick AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
NEXAM	52 Neutral	328.52M	-24.92	-4.91%	―	-3.42%	-31.37%
POLYG	43 Neutral	315.59M	-19.43	-3.70%	1.62%	21.21%	94.88%
ORGC	41 Neutral	kr189.76M	―	-74.60%	―	-16.35%	-33.91%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%